Find Academic Supervisors

Daniel DaleyView profile

Professor

• Biochemistry
• Protein Folding
• Bacterial Cell Biology
• +3 more

Daniel Daley is a Professor at the Department of Biochemistry and Biophysics, Stockholm University . His research group focuses on protein trafficking, folding, and assembly in bacterial cell factories , providing molecular insights into fundamental processes like protein secretion and cell division, with applications in engineering more efficient bacterial systems. His educational background includes a B.Sc. Hons and PhD in Biochemistry from the University of Western Australia . He is also a co-founder of biotech startups CloneOpt and Mycropt . Nationality: Australian (implied by education) Contact: daniel.daley@dbb.su.se Workplace: Room A433, Svante Arrhenius väg 16, Stockholm University Dr. Daley’s research integrates biochemistry, molecular biology, and advanced imaging techniques to study Gram-negative bacteria. His work on the divisome revealed its concentric ring structure via super-resolution microscopy, while his studies on chaperones like YfgM uncovered their roles in protein trafficking and substrate identification. His team also pioneered methods for optimizing protein production through translation initiation region engineering and codon substitution strategies. Key themes in his publications include: Cell division mechanics (divisome dynamics, FtsZ/FtsN separation) Protein folding and trafficking (YfgM substrates, SecYEG translocon) Biotechnological tools (TARSyn, CRISPRi validation) Membrane protein production (codon optimization, translation initiation)

Joshua RosenthalView profile

Researcher

• RNA Editing
• Molecular Biology
• Neurobiology
• +7 more

Joshua Rosenthal is a Senior Scientist at the Marine Biological Laboratory (MBL), affiliated with the University of Chicago. His research focuses on RNA editing, molecular biology, and neurobiology, particularly processes that modify genetic information in nucleic acids. He leads the Rosenthal Lab and is at the forefront of developing genetically tractable cephalopod models using CRISPR technology. Educational Background Biology B.A., Haverford College Biology Ph.D., Stanford University Dr. Rosenthal's work centers on A-to-I RNA editing via ADAR enzymes, a mechanism that allows precise single-base modifications in mRNA. His lab discovered unprecedented levels of mRNA recoding in cephalopods, exploring how environmental cues influence editing and how this could be harnessed for human therapeutics. The Rosenthal Lab develops site-directed RNA editing platforms to correct genetic mutations in diseases like cystic fibrosis, chronic pain, and cancer. They co-founded Korro Bio, a Cambridge MA-based biotech company commercializing RNA editing therapies. The lab also investigates structural and functional connectivity of squid chromatophores, revealing novel chromogenic behaviors in open-ocean species. Scientific contributions include 11 recent publications on RNA editing mechanisms, cephalopod genetics, and therapeutic applications. Research spans transcriptome plasticity, enzyme targeting, and marine organism adaptation.

Kristen W. LynchView profile

Professor

• RNA Biology
• Alternative Splicing
• Alternative Polyadenylation
• +7 more

Kristen W. Lynch, PhD, is the Benjamin Rush Professor of Biochemistry and Chair of the Department of Biochemistry and Biophysics at the Perelman School of Medicine, University of Pennsylvania. She leads research at the Lynch Lab and co-directs the Institute for RNA Innovation , focusing on RNA processing mechanisms in human immune responses. Education: Harvard University (B.A. 1990, Ph.D. 1996) Postdoctoral Training: University of California, San Francisco (1997-2001) Her work bridges RNA splicing , alternative polyadenylation , and gene regulation in immune cells and cancer. She discovered kinase pathways controlling RNA-binding protein (RBP) activity and demonstrated how antigen stimulation and viral infections reprogram splicing networks to modulate immunity. Collaborative studies with oncologists revealed splicing defects phenocopying genetic mutations in leukemias and identified therapeutic vulnerabilities in RNA processing . Her recent publications highlight TREX-2 complex in mRNA export, hnRNP L repressing cryptic exons, and DDX39B structural analysis . Collaborations span RNA-Seq , splicing codes , and epithelial cell post-transcriptional programs . She explores spliceosomal assembly mechanisms and signal-responsive RBPs in T cells and influenza pathogenesis.

Robert CarlisleView profile

Professor

• Biomedical Engineering
• Nanotechnology
• Cancer Therapy
• +7 more

Professor Robert Carlisle is a faculty member in the Faculty of Engineering Science at the University of Oxford , holding the title of Professor of Biomedical Engineering . He serves as Director of the MSc in Nanotechnology for Medicine and Healthcare and as Oxford Director for the Centre for Doctoral Training in Engineering Biology. BSc in Biochemistry, MSc in Toxicology, DPhil in Gene Delivery University of Birmingham (BSc, MSc, DPhil) His research interests focus on Biomedical Engineering and Drug Delivery , particularly the use of ultrasound , nanotechnology , and therapeutic formulation to enhance cancer treatments. He also explores vaccine development , antimicrobial resistance , and clinical translation of healthcare technologies. Recent publications highlight his work on cavitation-mediated drug delivery , thermosensitive liposomes , and ultrasound-triggered vaccine platforms . These studies span topics such as cancer immunotherapy , transdermal delivery , and clinical trial design for targeted therapies. Scientific awards include the CRS Jorge Heller JCR Outstanding Paper Award 2016 . His research has led to industrial collaborations and the co-founding of OxSonics Ltd , a spin-out company focused on oncology drug delivery.

• Biomedical Engineering
• Point-of-Care Testing
• Immunotherapy
• +5 more

Cassio Mendes Fontes is an Assistant Research Professor in the Department of Biomedical Engineering at Duke University. His research focuses on advancing point-of-care diagnostics, immunoassays, and biomaterials engineering for clinical and global health applications. Education: Ph.D. from Duke University (2020) Fontes' work spans biomedical engineering domains including immunotherapy, microfluidics, and nanotechnology. His publications highlight innovations in diagnostic platforms for diseases such as Ebola, talaromycosis, and cancer, often integrating smartphone-based or inkjet-printed technologies. Recent research trends include optimizing adjuvant release kinetics , engineering synthetic biomolecular condensates , and developing ultrasensitive biosensors . Collaborations with colleagues like Joh, Heggestad, and Chilkoti underscore interdisciplinary team-based approaches.

• Bacterial Toxin-Antitoxin Systems
• Molecular Biology
• Microbiology
• +4 more

Professor Kenn Gerdes at Newcastle University is a leading researcher in molecular microbiology, focusing on bacterial persistence mechanisms, toxin-antitoxin systems, and cell division regulation. His work bridges biochemistry, genetics, and systems biology. Key research areas include: RNA cleavage and translation inhibition by toxin-antitoxin modules Role of (p)ppGpp in bacterial dormancy Dynamics of plasmid segregation via ParA/ParB systems Structural analysis of bacterial cell division proteins His publications highlight collaborations with researchers like Dr. Kristoffer Winther, Dr. Etienne Maisonneuve, and Dr. Andrew Fenton. Articles span topics such as VapC toxin function , HipA-mediated persistence , and ParA ATPase dynamics , reflecting interdisciplinary contributions to bacterial physiology and antibiotic resistance. He has mentored numerous postgraduate researchers, including Dr. Kristoffer Winther and Dr. Etienne Maisonneuve, who co-authored studies on RNA interferases and plasmid segregation.

Zachary HudsonView profile

Professor

• Materials Science
• Organic Electronics
• Polymer Chemistry
• +4 more

Zachary Hudson is a Professor in the Department of Chemistry at the University of British Columbia . He received his B.Sc. and Ph.D. from Queen’s University and completed postdoctoral fellowships at the University of Bristol and the University of California, Santa Barbara . His research focuses on the synthesis of luminescent materials for optoelectronics , bioimaging , and organic photocatalysis , bridging organic , inorganic , and polymer chemistry .

• Microbiology
• Phytomyxea taxonomy and systematics
• Host-parasite interactions
• +7 more

Sigrid Neuhauser is a Full Professor (Univ.-Prof. Mag. Dr.) at the Institute of Microbiology , University of Innsbruck , where she also serves as Deputy Head of the Institute. She is a START-Fellow of the Austrian Science Fund (FWF) and leads a vibrant research group focused on Phytomyxea , phytopathology, and marine and soil microbiology. Education & Career: Current: Professor and Deputy Head, Institute of Microbiology, University of Innsbruck START-Fellow, Austrian Science Fund (FWF) Research Interests: Prof. Neuhauser’s work spans taxonomy and systematics of Phytomyxea , host-parasite interactions , phytopathology , and marine and soil microbiology . Her group uses cutting-edge molecular tools, including transcriptomics and single-cell RNA visualization (FISH), to unravel how biotrophic parasites interact with their hosts at the cellular level. She has pioneered studies on Plasmodiophora brassicae (clubroot) and Maullinia parasites of brown algae, and she leads the EU Marie Curie ITN ALFF – Algal friends and foes . Scientific Awards: START-Fellowship, Austrian Science Fund (FWF) Leadership & Grants: Principal Investigator, HiPhy – Understanding Phytomyxid-Host-Interactions (START-Grant, FWF) Partner, ALFF – Algal friends and foes (EU Marie Curie ITN) Coordinator, YETIS: Yeast Endophytes of VitIS sp. (applied research) Labs & Teams: She heads the Phytomyxea Research Group at the Institute of Microbiology, comprising post-docs, PhD students, and technical staff. The group operates state-of-the-art microscopy, molecular biology, and bioinformatics facilities.

Sebastian FalkView profile

Associate Professor

• RNA Processing
• RNA Surveillance
• Small Non-coding RNA Biology
• +3 more

Sebastian Falk is an Associate Professor at the Max Perutz Labs, part of the University of Vienna, within the Department of Structural and Computational Biology. His research focuses on the biogenesis and action of small RNAs, particularly piRNAs, employing structural biology and biochemical approaches to elucidate molecular mechanisms. He received the prestigious EMBO Young Investigator award in 2022. His lab investigates RNA surveillance pathways, mRNA splicing, and the interplay between RNA processing and degradation. Key projects include studying the MTR4-NRDE2-CCDC174 complex and piRNA processing factors in C. elegans. Falk has organized major symposia on RNA biology and contributed to high-impact publications in journals like Nature and Nucleic Acids Research . EMBO Young Investigator (2022) Grants: 'Characterization of piRNA processing factors in C. elegans' (2023-2026)

Stefan HüttelmaierView profile

Professor

• Molecular Biology
• Cancer Biology
• RNA Biology
• +3 more

Stefan Hüttelmaier is a Full Professor of Molecular Cell Biology at Martin-Luther University Halle-Wittenberg, Germany. He leads the Core Facility Imaging at the Charles Tanford Protein Center and directs research into RNA-binding proteins' roles in cancer. His career includes postdoctoral work at Albert Einstein College of Medicine and leadership roles in the RTG 1591 research group. His work focuses on RAVER1 protein dynamics, perinucleolar compartments, and RNA metabolism in cancer progression. Education: PhD in Biotechnology (2000, University of Braunschweig), postdoctoral training at Albert Einstein College of Medicine (2001–2004). Academic milestones include Associate Professor (2009) and Full Professor (2014) positions. Research spans RNA-protein interactions, cancer biology, and translational mechanisms in tumors. Key research interests include RNA-binding proteins' roles in cancer (RAVER1, IGF2BP1), alternative splicing, and miRNA regulation. His lab investigates how these molecules influence cancer cell behavior, metastasis, and therapeutic resistance. Recent work highlights druggable targets like IGF2BP1 and mechanisms linking RNA modifications to oncogenesis. Leadership roles include RTG 1591 speaker and Core Facility director. Publications emphasize RNA biology in cancer, with contributions to understanding post-transcriptional control and therapeutic strategies targeting RNA pathways. His interdisciplinary approach combines molecular biology, biochemistry, and computational modeling to address clinical challenges in oncology.

• Microbial Genetics
• Genomics
• Bioinformatics
• +4 more

Dr. Madhusudan Choudhary is a Professor in the Department of Biological Sciences at Sam Houston State University. He holds a Ph.D. from McMaster University and completed post-doctoral training at Duke University. His research laboratory focuses on microbial genetics, genomics, and bioinformatics using Rhodobacter sphaeroides as a model organism to study bacterial cell-cycle regulation, metabolic innovations through gene duplication, and the evolution of genomic complexity in prokaryotes. Key investigations include chromosome replication origins, duplicate gene expression patterns, and the functional specialization of multipartite genomes. Dr. Choudhary's research spans diverse areas including bacterial responses to microgravity, CRISPR-Cas systems, heavy metal resistance mechanisms, and nanoparticle interactions. He directs studies on transcriptomics under stress conditions and develops computational methods for genome analysis. His work has significant implications for understanding microbial evolution and environmental adaptation.

Anne WillisView profile

Professor

• Post-transcriptional Control
• RNA-binding Proteins
• Toxicology
• +4 more

Anne Willis is a Professor and Director of the MRC Toxicology Unit at the University of Cambridge, School of the Biological Sciences. Her research focuses on post-transcriptional control mechanisms in toxic injury, particularly involving RNA-binding proteins, regulatory RNA motifs, and tRNAs. She leads the Post-transcriptional control of gene expression following toxic injury program and collaborates on the Fibre Toxicity initiative. Biography Highlights : PhD in Biochemistry (University of London), Fellowships at BBSRC, EMBO member (2015), OBE (2017) Research Themes : Predictive adverse outcome models for toxicology, off-target effects of therapeutic RNAs, translational regulation in cancer Funding : Wellcome Trust LEAP grant, MRC (via Nucleic Acid Therapy Accelerator), Cancer Research Technologies Techniques : Mass spectrometry, Ribosome/polysome profiling, RBPome profiling Scientific Awards : OBE (2017) - Services to biomedical sciences and women in science BBSRC Advanced Fellowship (2000-2005) BBSRC Professorial Fellowship (2009-2013) EMBO membership (2015) Contact : tls36@cam.ac.uk | enquiries@mrc-tox.cam.ac.uk

Henri TiedgeView profile

Professor

• RNA Biology
• Neurobiology
• Translational Regulation
• +5 more

Henri Tiedge, PhD , is a Professor at the Department of Physiology and Pharmacology within SUNY Downstate Medical Center . His research focuses on regulatory brain cytoplasmic (BC) RNAs , particularly their role in translational control mechanisms at neuronal synapses and their implications in neurological disorders and tumor biology . Institutional Affiliation: SUNY Downstate Medical Center (College of Medicine, Physiology and Pharmacology) Academic Rank: Professor Research Domains: RNA Biology, Synaptic Plasticity, Neurodegeneration, Oncology Dr. Tiedge investigates how BC1 and BC200 RNAs regulate local protein synthesis in dendrites through interactions with eukaryotic initiation factors (eIF4A/B) . His work demonstrates that BC RNA dysregulation leads to neuronal hyperexcitability , epileptogenesis , and cognitive dysfunction , with therapeutic applications in neuropsychiatric lupus using RNA decoys. He also explores BC RNA expression in germ cells and tumors , aiming to develop diagnostic/prognostic tools for cancer. Key publications include studies on RNA transport via hnRNP A2 and Purα , autoantibody-induced RNA displacement , and cross-talk between BC RNAs and FMRP in fragile X syndrome. His work has been supported by NIH grants NS046769 and DA026110 .

Edward HutchinsonView profile

Professor

• Molecular Virology
• Influenza Virus
• Respiratory Viruses
• +4 more

Edward Hutchinson is a Professor of Molecular and Cellular Virology at the University of Glasgow’s Centre for Virus Research (CVR) , focusing on influenza and respiratory viruses. He leads a multidisciplinary team integrating virology, molecular biology, mass spectrometry, and structural biology to unravel virion formation, infectivity, and host interactions. Education: PhD in Molecular Biology of Influenza at University of Cambridge (supervised by Paul Digard), Postdoctoral Research at University of Oxford (Ervin Fodor), and Junior Research Fellow at Worcester College (2010–2014). Grants: Principal Investigator for MRC, BBSRC, and Wellcome Trust-funded projects, including the Influenza Virus Toolkit and Virus Dashboards. Research Interests: Hutchinson’s work centers on the molecular mechanisms of influenza virus replication, virion heterogeneity, and host-pathogen interactions. His lab investigates cryptic protein production, superinfection exclusion, and filamentous virion formation, bridging basic virology with pandemic preparedness. Recent Publications: His 15 most recent articles (2025–2019) highlight trends in influenza virus stability, SARS-CoV-2 coinfection dynamics, proteomic analysis of virions, and public health applications of virology. Notably, his 2025 Nature Communications study on thermal inactivation of influenza in milk and 2023 Nature paper on BTN3A3 evasion mechanisms underscore his impact on zoonotic transmission research. Scientific Recognition: Awards include the Microbiology Society ’s 2021 Outreach Prize, 2008 Biosciences Federation New Researcher Communication Award, and 2007 Young Microbiologist of the Year. He serves on grant panels (BBSRC, Royal Society) and editorial boards (Journal of General Virology). Advising & Collaboration: Supervises four PhD students and has mentored numerous researchers who now hold roles in academia, industry, and healthcare. His lab collaborates on reagent sharing, public engagement, and international virology initiatives like ESWI. Labs & Teams: Based at the CVR, his group develops tools like the Influenza Virus Toolkit and hosts public outreach events via partnerships with The Glasgow School of Art, creating AR apps and educational materials to visualize viruses.

• Microbiology
• Virology
• Molecular Biology
• +3 more

HACER MURATOĞLU is a Professor at the Department of Molecular Biology and Genetics , Karadeniz Technical University . Her research focuses on Microbiology , Virology , and Molecular Biology , particularly the study of entomopoxviruses and iridoviruses. She has contributed significantly to understanding viral protein functions, including protein kinases, glycosyltransferases, and nucleases, with applications in biological control and host-pathogen interactions . Her research spans several subfields: Viral Protein Kinases and Their Substrate Specificity Glycosyltransferase Enzymatic Activities Baculovirus Vector Engineering Bacterial Pathogens in Insect Pests Transcriptome-Based Pathogen Discovery Viral Pathogenesis Mechanisms She has received funding from TUBITAK and Higher Education Institutions for projects such as: Vaccine Development for SARS-CoV-2 Functional Analysis of AMEV Protein Kinases Iridovirus Gene Expression Studies Her work has been peer-reviewed for journals like Turkish Journal of Biology and Turkish Journal of Botany .